380 related articles for article (PubMed ID: 23974956)
41. Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma.
Cardenas MG; Yu W; Beguelin W; Teater MR; Geng H; Goldstein RL; Oswald E; Hatzi K; Yang SN; Cohen J; Shaknovich R; Vanommeslaeghe K; Cheng H; Liang D; Cho HJ; Abbott J; Tam W; Du W; Leonard JP; Elemento O; Cerchietti L; Cierpicki T; Xue F; MacKerell AD; Melnick AM
J Clin Invest; 2016 Sep; 126(9):3351-62. PubMed ID: 27482887
[TBL] [Abstract][Full Text] [Related]
42. AID-associated DNA repair pathways regulate malignant transformation in a murine model of BCL6-driven diffuse large B-cell lymphoma.
Gu X; Booth CJ; Liu Z; Strout MP
Blood; 2016 Jan; 127(1):102-12. PubMed ID: 26385350
[TBL] [Abstract][Full Text] [Related]
43. Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice.
Cattoretti G; Pasqualucci L; Ballon G; Tam W; Nandula SV; Shen Q; Mo T; Murty VV; Dalla-Favera R
Cancer Cell; 2005 May; 7(5):445-55. PubMed ID: 15894265
[TBL] [Abstract][Full Text] [Related]
44. The endless complexity of lymphocyte differentiation and lymphomagenesis: IRF-4 downregulates BCL6 expression.
Lossos IS
Cancer Cell; 2007 Sep; 12(3):189-91. PubMed ID: 17785200
[TBL] [Abstract][Full Text] [Related]
45. High expression of LMO2 in Hodgkin, Burkitt and germinal center diffuse large B cell lymphomas.
Shams TM
J Egypt Natl Canc Inst; 2011 Dec; 23(4):147-53. PubMed ID: 22776842
[TBL] [Abstract][Full Text] [Related]
46. Heterologous promoters fused to BCL6 by chromosomal translocations affecting band 3q27 cause its deregulated expression during B-cell differentiation.
Chen W; Iida S; Louie DC; Dalla-Favera R; Chaganti RS
Blood; 1998 Jan; 91(2):603-7. PubMed ID: 9427715
[TBL] [Abstract][Full Text] [Related]
47. miR-10a inhibits cell proliferation and promotes cell apoptosis by targeting BCL6 in diffuse large B-cell lymphoma.
Fan Q; Meng X; Liang H; Zhang H; Liu X; Li L; Li W; Sun W; Zhang H; Zen K; Zhang CY; Zhou Z; Chen X; Ba Y
Protein Cell; 2016 Dec; 7(12):899-912. PubMed ID: 27815824
[TBL] [Abstract][Full Text] [Related]
48. Immunohistochemical profile and fluorescence in situ hybridization analysis of diffuse large B-cell lymphoma in northern China.
Li T; Medeiros LJ; Lin P; Yin H; Littlejohn M; Im W; Lennon PA; Hu P; Jorgensen JL; Liang M; Guo H; Yin CC
Arch Pathol Lab Med; 2010 May; 134(5):759-65. PubMed ID: 20441508
[TBL] [Abstract][Full Text] [Related]
49. Structure of the MADS-box/MEF2 domain of MEF2A bound to DNA and its implication for myocardin recruitment.
Wu Y; Dey R; Han A; Jayathilaka N; Philips M; Ye J; Chen L
J Mol Biol; 2010 Mar; 397(2):520-33. PubMed ID: 20132824
[TBL] [Abstract][Full Text] [Related]
50. CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas.
Jiang Y; Ortega-Molina A; Geng H; Ying HY; Hatzi K; Parsa S; McNally D; Wang L; Doane AS; Agirre X; Teater M; Meydan C; Li Z; Poloway D; Wang S; Ennishi D; Scott DW; Stengel KR; Kranz JE; Holson E; Sharma S; Young JW; Chu CS; Roeder RG; Shaknovich R; Hiebert SW; Gascoyne RD; Tam W; Elemento O; Wendel HG; Melnick AM
Cancer Discov; 2017 Jan; 7(1):38-53. PubMed ID: 27733359
[TBL] [Abstract][Full Text] [Related]
51. Prognostic significance of B-cell differentiation genes encoding proteins in diffuse large B-cell lymphoma and follicular lymphoma grade 3.
Borovecki A; Korać P; Nola M; Ivanković D; Jaksić B; Dominis M
Croat Med J; 2008 Oct; 49(5):625-35. PubMed ID: 18925696
[TBL] [Abstract][Full Text] [Related]
52. Pattern of MEF2B expression in lymphoid tissues and in malignant lymphomas.
Krenács D; Borbényi Z; Bedekovics J; Méhes G; Bagdi E; Krenács L
Virchows Arch; 2015 Sep; 467(3):345-55. PubMed ID: 26089142
[TBL] [Abstract][Full Text] [Related]
53. Primary diffuse large B-cell lymphoma of the oral cavity: germinal center classification.
Bhattacharyya I; Chehal HK; Cohen DM; Al-Quran SZ
Head Neck Pathol; 2010 Sep; 4(3):181-91. PubMed ID: 20533006
[TBL] [Abstract][Full Text] [Related]
54. Kaiso is a key regulator of spleen germinal center formation by repressing Bcl6 expression in splenocytes.
Koh DI; Yoon JH; Kim MK; An H; Kim MY; Hur MW
Biochem Biophys Res Commun; 2013 Dec; 442(3-4):177-82. PubMed ID: 24269670
[TBL] [Abstract][Full Text] [Related]
55. Expression of the human germinal center-associated lymphoma (HGAL) protein, a new marker of germinal center B-cell derivation.
Natkunam Y; Lossos IS; Taidi B; Zhao S; Lu X; Ding F; Hammer AS; Marafioti T; Byrne GE; Levy S; Warnke RA; Levy R
Blood; 2005 May; 105(10):3979-86. PubMed ID: 15677569
[TBL] [Abstract][Full Text] [Related]
56. Mechanisms of action of BCL6 during germinal center B cell development.
Huang C; Melnick A
Sci China Life Sci; 2015 Dec; 58(12):1226-32. PubMed ID: 26566802
[TBL] [Abstract][Full Text] [Related]
57. Smc3 dosage regulates B cell transit through germinal centers and restricts their malignant transformation.
Rivas MA; Meydan C; Chin CR; Challman MF; Kim D; Bhinder B; Kloetgen A; Viny AD; Teater MR; McNally DR; Doane AS; Béguelin W; Fernández MTC; Shen H; Wang X; Levine RL; Chen Z; Tsirigos A; Elemento O; Mason CE; Melnick AM
Nat Immunol; 2021 Feb; 22(2):240-253. PubMed ID: 33432228
[TBL] [Abstract][Full Text] [Related]
58. AID is expressed in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas and is not correlated with intraclonal heterogeneity.
Lossos IS; Levy R; Alizadeh AA
Leukemia; 2004 Nov; 18(11):1775-9. PubMed ID: 15385936
[TBL] [Abstract][Full Text] [Related]
59. Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas.
Ding BB; Yu JJ; Yu RY; Mendez LM; Shaknovich R; Zhang Y; Cattoretti G; Ye BH
Blood; 2008 Feb; 111(3):1515-23. PubMed ID: 17951530
[TBL] [Abstract][Full Text] [Related]
60. Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma.
Iqbal J; Greiner TC; Patel K; Dave BJ; Smith L; Ji J; Wright G; Sanger WG; Pickering DL; Jain S; Horsman DE; Shen Y; Fu K; Weisenburger DD; Hans CP; Campo E; Gascoyne RD; Rosenwald A; Jaffe ES; Delabie J; Rimsza L; Ott G; Müller-Hermelink HK; Connors JM; Vose JM; McKeithan T; Staudt LM; Chan WC;
Leukemia; 2007 Nov; 21(11):2332-43. PubMed ID: 17625604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
